Abstract
18F-flurodeoxyglycose (FDG)/13N-ammonia positron emission tomography/computed tomography (PET/CT) is frequently utilized to evaluate cardiac sarcoidosis (CS) but findings can reflect other forms of myocardial inflammation or altered myocardial metabolic activity. Herein, we present five cases where cardiac PET findings suggested CS, but right ventricular endomyocardial biopsy samples revealed ATTR-type cardiac amyloidosis.
Similar content being viewed by others
Abbreviations
- ATTR-CM:
-
Transthyretin amyloid cardiomyopathy
- CMR:
-
Cardiac magnetic resonance imaging
- CS:
-
Cardiac sarcoidosis
- EF:
-
Ejection fraction
- EMBx:
-
Endomyocardial biopsy
- 18F-FDG:
-
18F-flurodeoxyglycose
- GLS:
-
Global longitudinal strain
- H/CL:
-
Heart to contralateral lung
- LC-MS/MS:
-
Liquid chromatography-tandem mass spectrometry
- LV:
-
Left ventricular
- PET/CT:
-
Positron emission tomography/computed tomography
- PVC:
-
Premature ventricular contraction
- PYP:
-
99MTechnetium-pyrophosphate
- SPECT/CT:
-
Single photon emission computed tomography/computed tomography
- TTE:
-
Transthoracic echocardiogram
- TTR:
-
Transthyretin
- VT:
-
Ventricular tachycardia
References
Bois JP, Muser D, Chareonthaitawee P. PET/CT evaluation of cardiac sarcoidosis. PET Clin 2019;14:223‐32.
Chareonthaitawee P, Beanlands RS, Chen W, Dorbala S, Miller EJ, Murthy VL. Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Med 2017;58:1341‐53.
Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014;11:1305‐23.
Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, et al. JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis-digest version. Circ J 2019;83:2329‐88.
Elwazir MY, Bois JP, Abou Ezzeddine OF, Chareonthaitawee P. Imaging and quantification of cardiac sarcoidosis. Semin Nucl Med 2020;50:283‐94.
Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS. Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 2019;73:2872‐91.
Dasari S, Theis JD, Vrana JA, Rech KL, Dao LN, Howard MT, et al. Amyloid typing by mass spectrometry in clinical practice: A comprehensive review of 16,175 samples. Mayo Clin Proc 2020;95:1852‐64.
Vaidya VR, Abudan AA, Vasudevan K, Shantha G, Cooper LT, Kapa S, et al. The efficacy and safety of electroanatomic mapping-guided endomyocardial biopsy: A systematic review. J Interv Card Electrophysiol 2018;53:63‐71.
Mohammed SF, Mirzoyev SA, Edwards WD, Dogan A, Grogan DR, Dunlay SM, et al. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail 2014;2:113‐22.
Siegismund CS, Escher F, Lassner D, Kuhl U, Gross U, Fruhwald F, et al. Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis. Eur J Heart Fail 2018;20:751‐7.
Funding
No funding support for this work.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Young, K.A., Lyle, M., Rosenbaum, A.N. et al. 18F-FDG/13N-ammonia cardiac PET findings in ATTR cardiac amyloidosis. J. Nucl. Cardiol. 30, 726–735 (2023). https://doi.org/10.1007/s12350-021-02886-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-021-02886-2